Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Wnt/β-catenin

Items 11-20 of 40

Page
per page
  1. CHIR-99021 (CT99021)
    A3011 CHIR-99021 (CT99021)
     2 Citation
    Target: GSK-3
    Summary: GSK-3 inhibitor, Cell-permeable, ATP-competitive
      ≥23.27 mg/mL
  2. JW 55
    A4529 JW 55
    Summary: PARP domain inhibitor
      insoluble in H2O; ≥19.25 mg/mL
  3. KY 02111
    A8213 KY 02111
    Summary: WNT signaling inhibitor
      insoluble in H2O; ≥18.85 mg/mL
  4. ICG 001
    A8217 ICG 001
     1 Citation
    Summary: Wnt/β-catenin pathway inhibitor
      ≥27.43 mg/mL
  5. XAV-939
    A1877 XAV-939
     1 Citation
    Target: TNKS
    Summary: Tankyrase 1/2 inhibitor
      insoluble in H2O; insoluble in EtOH; ≥15.62 mg/mL
  6. Wnt agonist 1
    B6059 Wnt agonist 1
     1 Citation
    Summary: agonist of Wnt signaling pathway
      ≥38.7 mg/mL
  7. IWP-3
    C3254 IWP-3
    Summary: inhibitor of Wnt production
      ≤0.1 mg/mL
  8. IWP-2-V2
    C3625 IWP-2-V2
    Summary: Wnt production inhibitor
      ≤2 mg/mL
  9. Windorphen
    B5977 Windorphen
    Summary: Wnt inhibitor
      insoluble in EtOH; insoluble in H2O; ≥11.45 mg/mL
  10. CCT251545
    B5979 CCT251545
    Summary: Orally bioavailable and potent WNT signaling inhibitor
      ≥42.2 mg/mL

Items 11-20 of 40

Page
per page